Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved Notified -
Have We Lost Our Sense of Spontaneity? New Research From Desperados Reveals Less Than 1 in 10 of Us Make Plans With Less Than 24 Hours' Notice Notified -
Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis Notified -